Effect of ureteric stents on urological infection and graft function following renal transplantation

Table 3 Effect of stent use on various outcome parameters, and infection and type of urological infection on allograft function

	Cr6	Cr12	eGFR6	eGFR12
Stent
Yes
mean ± SE	137.5 ± 4.6	139.7 ± 4.7	50.9 ± 1.3	49.9 ± 1.3
Median	123.5	125	52	49.5
n	180	176	180	176
No
mean ± SE	132.4 ± 5.6	124.4 ± 5.4	52.1 ± 1.9	54.8 ± 2.1
Median	120.5	120	52	55
n	78	74	77	73
F-statistic	0.42	3.603	0.256	4.047
P value	0.517	0.059	0.614	0.045
Parameters
Infection
Yes
mean ± SE	143.1 ± 6.2	144.0 ± 6.2	49.5 ± 1.6	48.9 ± 1.7
n	121	118	120	117
No
mean ± SE	128.0 ± 4.0	125.5 ± 4.3	53.4 ± 1.4	54.4 ± 1.4
n	123	119	123	119
F-statistic	2.232	3.123	2.154	4.038
P value	0.109	0.046	0.118	0.019
Infection type
UTI
mean ± SE	140.6 ± 6.9	139.8 ± 6.8	50.2 ± 1.8	50.3 ± 1.8
n	105	104	104	103
MUI
mean ± SE	156.4 ± 11.5	167.6 ± 11.6	45.8 ± 3.8	41.3 ± 3.7
n	18	16	18	16
F-statistic	0.558	1.299	0.524	1.783
P value	0.574	0.277	0.593	0.173

UTI: Urinary tract infection; MUI: Major urological infection; Cr₆: Creatinine at 6 mo; Cr₁₂: Creatinine at 12 mo; eGFR₁₂: Estimated glomerular filtration rate at 12 mo; eGFR₆: Estimated glomerular filtration rate at 6 mo.